reSee.it - Related Video Feed

Dr. Scott Sherr discusses a clinician’s shift from conventional, disease-focused care to a health optimization model that emphasizes preventative foundations, metabolic resilience, and mitochondria as central to wellness. He explains his background in internal medicine and Health Optimization Medicine, a framework aimed at maintaining health rather than merely treating disease, and describes how metabolomics and laboratory testing underpin his approach. The conversation frames acute, interventional care as where Western medicine excels, while highlighting the gaps in prevention and long-term disease reversal in standard primary care. A central theme is energy production at the cellular level: how mitochondria generate ATP, manage oxidative stress, and how insulin resistance and sympathetic dominance erode metabolic capacity. The hosts and guest explore practical strategies to overcome these bottlenecks, stressing that improvements rarely occur overnight and often require gradual nervous-system downregulation, lifestyle adjustments, and targeted supplementation to restore balance and energy. The episode then dives into methylene blue as a versatile metabolic bridge: a long-standing compound with antimicrobial history that, at low doses, supports mitochondrial function and energy production, and at higher doses acts as an antimicrobial. Dr. Sherr details its redox cycling mechanisms, its ability to bypass mitochondrial blockages, and how it can rapidly influence energy and detoxification, sometimes within days. The discussion covers safety considerations, including serotonin syndrome risk when combined with certain antidepressants, and emphasizes monitoring dose through gradual titration using troches, with typical ranges for many individuals around 4-16 mg daily. The conversation also links methylene blue to performance and recovery, including travel-related hypoxic stress, and mentions synergistic stacking with red-light therapy and other mitochondrial supports. Practical lifestyle strategies emerge: prioritize sleep hygiene, parasympathetic activation, and consistent routines to improve HRV and brain function; acknowledge the importance of not overtraining in a stressed state; and use supplements as a bridge while implementing foundational changes. Toward the end, the guests touch on cordycepin from Cordyceps for sleep and immune support, GABA-related calming formulations, and the broader concept of cellular medicine as medicine evolves toward optimizing mitochondrial health as a pathway to better mental and physical performance.

A recent discussion centers on how regular, appropriately timed light exposure may influence longevity, metabolic health, mood, and sleep, anchored by human studies and controlled trials. The conversation emphasizes dose-dependent patterns of sun exposure: more time outdoors correlates with better health outcomes across large cohorts, including reductions in all-cause mortality and cardiovascular events. While emphasizing correlation rather than strict causation, the speakers highlight replication of findings in different populations and the consistency of results with evolutionary expectations about outdoor living. The dialogue then shifts to the mechanisms, focusing on mitochondria as energy hubs that respond to red and infrared wavelengths. Red and near-infrared light are described as penetrating tissues and modulating mitochondrial function, which can influence ATP production, reactive oxygen species balance, and the production of mitochondrial melatonin, a powerful antioxidant produced inside cells. This subcellular melatonin is said to be generated in response to infrared light and to bolster antioxidant defenses more broadly than pineal melatonin, with implications for metabolic regulation and protection against modern light pollution. The host and guest discuss practical interventions, including a structured 21-day light challenge with a beginner track of morning and evening sun exposure, midday outdoor meals, and evening light dimming or amber-tinted eye protection. They stress “habit stacking” to integrate outdoor time into daily routines, such as walking outside with a dog or taking breaks outdoors, and caution against overexposure or burning. The advanced plan adds strategies such as viewing sunrise to leverage spectral shifts, midday sunbathing for optimal UV balance, and lower-level indoor lighting adjustments, including the use of incandescent bulbs to approximate evolutionary firelight. Throughout, they emphasize the importance of reducing blue light at night, using color filters on devices, and creating a built environment that aligns with circadian biology. A personal backdrop is shared about Jonathan’s journey and his motivation to translate research into accessible, actionable practices for broader health improvements, underscoring that even small, consistent changes can yield meaningful benefits over time.

Dr. Scott Sherr, an expert in hyperbaric oxygen therapy and methylene blue, discusses his journey from conventional to integrative medicine, emphasizing the importance of optimizing health rather than merely treating disease. He highlights hyperbaric oxygen therapy as a powerful healing modality that combines increased oxygen levels and atmospheric pressure to enhance oxygen delivery in the body, which can reverse low oxygen states, reduce inflammation, and stimulate stem cell release. However, he notes that not everyone benefits from hyperbaric therapy, particularly those with chronic conditions, as they may require foundational health optimization first. Sherr explains that 94% of the U.S. population experiences some mitochondrial dysfunction, which affects energy production and detoxification. He advocates for a comprehensive approach that includes optimizing diet, lifestyle, and nutrient intake alongside therapies like methylene blue, which he describes as a mitochondrial optimizer that enhances energy production and detoxification. Methylene blue has a storied history as an antimicrobial and is known for its ability to support mitochondrial function, particularly in conditions like Alzheimer's and traumatic brain injuries. He also addresses the accessibility of hyperbaric therapy, noting that while soft chambers for home use are becoming more common, they can be expensive. Sherr emphasizes the importance of understanding individual health goals when considering hyperbaric therapy or methylene blue, advocating for a personalized approach to health optimization. He concludes by stressing the significance of education in health practices and the need for integrative strategies to maintain optimal health.

The discussion begins with the viral topic of methylene blue, highlighted by a video of Robert Kennedy using it. The hosts emphasize a current Renaissance in biohacking, suggesting that we have the tools to address various health issues. Jay Campbell shares his experience of recovering from a torn quad using growth hormone peptides, red light therapy, and other techniques to enhance healing. Alex Kikel explains methylene blue's multifaceted benefits, including its ability to increase cGMP levels, enhance energy production via the electron transport chain, and assist in fat loss and tumor treatment. The conversation touches on its historical use as a dye and its potential in neuroinflammation treatment, particularly in conditions like TBI and Alzheimer's. Kikel mentions the importance of dosing, noting that while some may experience hyperstimulation, others may benefit from lower doses. The hosts discuss the role of creatine, with Kikel advocating for higher doses based on individual response, emphasizing its effectiveness in muscle gain and fat loss. They also explore the neuroprotective properties of methylene blue and its interaction with other compounds like nicotine, which can enhance cognitive function and reduce neuroinflammation. Kikel shares his extensive background in human performance and coaching, highlighting his experience with professional athletes and the importance of individualized approaches to health and performance. He notes that many high-level athletes utilize specialized coaches to optimize their training and nutrition beyond traditional medical advice. The conversation shifts to the use of peptides and supplements in bodybuilding, discussing the importance of insulin, carnitine, and choline for muscle growth and recovery. Kikel emphasizes the need for a comprehensive approach that includes nutrition, training, and supplementation to achieve optimal results. They also delve into the potential of GLP-1s in bodybuilding, noting their effectiveness in managing appetite and promoting fat loss, while cautioning against their use in individuals requiring high caloric intake. The hosts conclude by discussing the importance of foundational health practices, such as proper nutrition and sleep, before introducing advanced supplements and therapies. Overall, the dialogue reflects a blend of cutting-edge health strategies, personal anecdotes, and a focus on individualized approaches to wellness and performance enhancement.

In this episode of The Drive, host Peter Attia welcomes Francisco Gonzalez-Lima, a professor of neuroscience and pharmacology at the University of Texas, Austin, to discuss Alzheimer's disease. Gonzalez-Lima presents the vascular hypothesis of Alzheimer's, which suggests that the central issue in late-onset Alzheimer's is a progressive neuronal energy crisis due to impaired blood flow and mitochondrial respiration in the brain. He argues that improving energy supply and blood flow could aid in preventing Alzheimer's disease. Gonzalez-Lima explains his background as a behavioral neuroscientist and his journey from studying animal behavior to understanding the brain's functional mapping. He emphasizes the brain's unique structure and function compared to other organs, highlighting its complexity and the importance of understanding its redundancy and parallel processing systems. The conversation shifts to the historical context of Alzheimer's disease, noting that the original observations by Alois Alzheimer in 1907 do not accurately represent the disease as it manifests in older populations. Gonzalez-Lima criticizes the amyloid-beta hypothesis, stating that it has led to significant failures in treatment and understanding of Alzheimer's. He asserts that the disease is primarily related to aging and that the focus should be on vascular health and energy metabolism rather than solely on amyloid plaques. Attia and Gonzalez-Lima discuss the implications of mitochondrial dysfunction in Alzheimer's, including the role of cytochrome oxidase in energy production. They explore how compromised circulation and energy supply can lead to cognitive decline, emphasizing the need for interventions that target mitochondrial function. Gonzalez-Lima introduces methylene blue as a potential therapeutic agent that can enhance mitochondrial respiration and protect against neurodegeneration. He explains its historical use and how it can act as an electron donor in the electron transport chain, potentially reversing some of the damage associated with Alzheimer's. The discussion also touches on the importance of lifestyle factors, such as diet and exercise, in maintaining brain health. Gonzalez-Lima advocates for a ketogenic diet as a means to support mitochondrial function and energy supply to the brain. Finally, they discuss the potential for near-infrared light therapy to stimulate mitochondrial function and improve cognitive outcomes. Gonzalez-Lima expresses hope for future clinical trials to validate these approaches and emphasizes the need for a shift in focus from treating established dementia to preventing cognitive decline through metabolic and vascular health interventions.

Light is described as a pervasive biological signal that the body translates into electrical, hormonal, and genetic activity. The host explains how different wavelengths of light penetrate tissues to varying depths and how photoreceptors in the eye, along with skin cells, relay light information to brain circuits and endocrine systems. A key emphasis is that light exposure influences melatonin production via intrinsically photosensitive melanopsin cells, linking daily and seasonal cycles to sleep, mood, and overall physiology. The discussion highlights how melatonin serves as a transducer of environmental light, guiding physiological timing across the year, and notes that bright indoor light can suppress melatonin with consequences for sleep, mood, and circadian alignment. The host also covers how exposure to ultraviolet B light through the skin or eyes can acutely raise sex hormones, affect fertility markers, and alter mate behavior in animal models, while acknowledging differences in humans. The broader point is that light signals modulate regulatory and protective hormonal processes, immune function, and tissue renewal, with seasonal patterns shaping experiences of energy and well-being. Practical guidance includes balancing outdoor light exposure across seasons, considering blue-light blocking, and using devices like light panels or SAD lamps to support mood and circadian health in darker months. Cautions are raised about excessive bright light, especially at night, and about individual risk factors for skin or eye disease when increasing UV exposure. The overview also touches how red and near-infrared light can penetrate deeper tissues to influence mitochondria, boost ATP, reduce reactive oxygen species, and potentially support skin healing and neuronal function, including research in aging vision and the potential for improving older adults’ visual performance.

The episode centers on hydrogen as a therapeutic agent, with Tyler LeBaron outlining why molecular hydrogen, not alkaline pH, drives the benefits attributed to hydrogen-related therapies. The discussion opens by clarifying that dissolving hydrogen gas in water does not alter the water’s pH or structure; rather, hydrogen serves as a selective antioxidant that targets harmful free radicals while preserving beneficial signaling. The guest emphasizes the stagnation of many alkaline-water claims once hydrogen is removed, citing a Nature Medicine study in a stroke model where 2% hydrogen gas reduced brain damage and improved survival, thus highlighting hydrogen’s potential mechanism rather than the alkalinity itself. Throughout the interview, the duo traces hydrogen’s journey from early curiosity sparked by alkaline ionized water research to the modern understanding of how hydrogen interacts with mitochondria, redox signaling, and NRF2-regulated antioxidant defenses. A key mechanistic highlight is hydrogen’s apparent targeting of the Rieske iron-sulfur protein in mitochondrial complex III, triggering a controlled, hormetic spike in reactive oxygen species that then prompts mitochondrial biogenesis and improved energy production, without suppressing essential redox signaling. The conversation also contrasts hydrogen’s selective antioxidant activity with conventional, non-selective antioxidants, explaining why Hydrogen can support redox homeostasis without blunting adaptive responses evoked by exercise or stress. The host and guest discuss multiple clinical domains, including athletic performance, cognitive function, metabolic syndrome, PMS/PCOS–related concerns, and aging-related redox dynamics, noting that most evidence comes from cell culture, animal models, and preliminary human trials. They emphasize the importance of dosage form (drinking water, tablets, or inhalation) and dosing strategy while acknowledging the need for more robust human trials. In closing, they frame hydrogen as a redox adaptogen that can modulate mitochondrial function and inflammatory pathways, potentially offering broad, safe benefits when integrated with standard health practices such as sleep, nutrition, and exercise.